Letters to the Editor

Real-world outcomes of venetoclax plus hypomethylating agents in BPDCN across treatment lines

University of Miami Miller School of Medicine, Medical Scientist Training Program, Miami, FL, United States; University of Miami Miller School of Medicine, Sheila and David Fuente Graduate Program in Cancer Biology, Miami, FL, United States; University of Miami Miller School of Medicine, Sylvester Comprehensive Cancer Center, Miami, FL
Dana-Farber Cancer Institute, Department of Medical Oncology, Boston, MA
University of Miami Miller School of Medicine, Sylvester Comprehensive Cancer Center, Miami, FL
Dana-Farber Cancer Institute, Department of Medical Oncology, Boston, MA
University of Miami Miller School of Medicine, Sylvester Comprehensive Cancer Center, Miami, FL
Haematologica Early view Aug 27, 2026 https://doi.org/10.3324/haematol.2026.301363